🔎 Trials Near Me

Home › Autoimmune Diseases › District of Columbia › Washington

Autoimmune Diseases clinical trials in Washington, DC

19 studies for Autoimmune Diseases are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

RecruitingPhase 1
  • MedStar Georgetown University Hospital, Washington D.C.
  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi away
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT03816345

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

RecruitingObservational studyHealthy volunteers welcome
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT00867269

Natural History of Bronchiectasis

RecruitingObservational studyHealthy volunteers welcome
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 5 to 100 · All sexes · Updated Oct 2, 2026 · NCT00943514

NIAID Centralized Sequencing Protocol

RecruitingObservational studyHealthy volunteers welcome
  • Children's National Health System, Washington D.C.
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
1 Day – 100 Years · All sexes · Updated Oct 2, 2026 · NCT03206099

Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

RecruitingPhase 2Healthy volunteers welcome
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 4 to 75 · All sexes · Updated Sep 28, 2026 · NCT02579967

Environmental Risk Factors for the Anti-synthetase Syndrome

RecruitingObservational studyHealthy volunteers welcome
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 2 to 100 · All sexes · Updated Sep 28, 2026 · NCT01276470

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

RecruitingPhase 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 4 to 69 · All sexes · Updated Sep 28, 2026 · NCT04339777

Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

RecruitingPhase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 18 to 70 · All sexes · Updated Sep 28, 2026 · NCT04097561

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

RecruitingObservational study
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
1 Month – 100 Years · All sexes · Updated Sep 24, 2026 · NCT00246857

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

RecruitingObservational study
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Up to age 99 · All sexes · Updated Sep 24, 2026 · NCT00001350

Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

RecruitingPhase 2
  • National Naval Medical Center, Bethesda · 7 mi away
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 18 to 90 · All sexes · Updated Sep 22, 2026 · NCT00977977

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3
  • Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
  • American Oncology Partners of Maryland, PA, Bethesda · 7 mi away
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

RecruitingPhase 2/3
  • National Institutes of Health - Accepting Adult and Juvenile Patients, Bethesda · 7 mi away
Ages 6 to 75 · All sexes · Updated Sep 17, 2026 · NCT06154252

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RecruitingPhase 3
  • Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

RecruitingPhase 3
  • Site Number - 1024, Washington D.C.
Ages 18 to 80 · All sexes · Updated Jul 30, 2026 · NCT07039916

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

RecruitingPhase 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 18 to 75 · All sexes · Updated Jul 10, 2026 · NCT05027945

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • Children's National Medical Center, Washington D.C.
  • Nih/Niaid, Bethesda · 7 mi away
  • Nih/Nhlbi, Bethesda · 7 mi away
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

RecruitingPhase 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 3 to 99 · All sexes · Updated Mar 9, 2026 · NCT04304820

X-linked Moesin Associated Immunodeficiency

RecruitingObservational study
  • National Institutes of Health, Bethesda · 7 mi away
Ages 4 to 80 · Men · Updated Apr 25, 2025 · NCT06278337

About Autoimmune Diseases

Autoimmune diseases are where your immune system attacks healthy cells in your body by mistake. Learn about the symptoms, tests, and treatments.

More about Autoimmune Diseases on MedlinePlus

Autoimmune Diseases trials in other cities

Other studies in Washington

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.